We provide a unified workflow transitioning from high-throughput in vitro phenotypic screenings to sophisticated in vivo spontaneous metastasis models, ensuring continuity and reliable data.
Pharmacologic Anti-Metastasis Validation Service
Creative Biolabs provides specialized laboratory services to evaluate the anti-metastatic potential of novel compounds across the entire invasion-metastasis cascade. We provide high-resolution imaging, molecular profiling, and orthotopic modeling to track systemic dissemination. By partnering with us, our clients gain actionable data on colonization efficiency and phenotypic plasticity, allowing for a more informed selection of lead candidates during the research and development phase.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Research Background: Pharmacologic Anti-Metastasis Validation Platforms
Metastasis remains a primary challenge in oncology research. As established in literature, the metastatic cascade is a multi-step process involving EMT, survival in circulation, and the rate-limiting step of colonization. Recent findings further emphasize the role of the pre-metastatic niche and extracellular vesicles in preparing distal soils. Creative Biolabs' service integrates these biological principles to provide a systemic evaluation of anti-cancer agents, ensuring that dormant and plastic cell populations are effectively targeted in laboratory settings.
Request a Consultation →
Fig.1 Tumor metastatic colonization to the distant organs is a multi-step process. 1
What We Can Offer
One-stop Validation Pipeline
Customized Protocol Design
Our team develops tailored study parameters focusing on specific organ-tropism, such as Blood-Brain Barrier penetration or Bone-Niche cycles, to match your candidate's profile.
Large-Scale Multi-Organ Capacity
Utilize our high-capacity imaging systems for simultaneous longitudinal tracking across multiple distal sites, including the lungs, liver, bone, and brain, within single studies.
Rigorous Quality Systems
We integrate research-based quality control principles and process analytical techniques into every assay to ensure exceptional data reproducibility and technical consistency.
How Creative Biolabs Can Assist Your Project
Highlights
Integrative Research Framework
Creative Biolabs leads the industry by merging core biological principles of cancer dissemination with high-throughput testing to provide actionable insights for drug development.
Specialized MRD Focus
Our unique focus on Minimal Residual Disease and dormancy-breaking makes us the ideal partner for biopharmaceutical teams seeking to prevent future relapse.
Evidence-Based Validation
We utilize established research frameworks to ensure every study is grounded in the latest scientific consensus, delivering high-fidelity results for your project.
Unrivaled Technical Expertise
By combining sophisticated modeling with precision analytics, we offer researchers a superior validation environment that exceeds standard laboratory expectations and industry benchmarks.
To secure high-fidelity data that accelerates your research milestones - Get a Quote Today.
Customer Reviews
-
Incredible insight into Niche Priming
Using Creative Biolabs' service in our research has improved our understanding of how our candidate blocks vesicle-mediated liver preparation. The vesicle isolation data was more precise than our internal methods. - Dr. A***n. L. -
True Anti-Metastatic Validation
Unlike methods that only use tail-vein injections, Creative Biolabs' resection model helped differentiate between primary growth inhibition and actual anti-dissemination effects. - M**l. R.
FAQs
Can you work with our proprietary PDX models?
Yes, we specialize in adapting researcher-provided patient-derived xenografts into our validated orthotopic and resection-based workflows, ensuring that your specific model's metastatic characteristics are preserved.
What species do you typically use for these studies?
Our laboratory primarily utilizes immunodeficient mouse models for human cell line validation, alongside syngeneic models to investigate the role of the immune system in metastasis research.
Related Services
ECM Remodeling & Protease Activity Analysis Service
This service quantifies extracellular matrix degradation and protease enzymatic activity to evaluate how research compounds inhibit the invasive breakdown of tissue barriers during metastasis.
Learn More →Microfluidic Anti-Invasion Compound Test Service
Our chip-based platform evaluates how research compounds inhibit cell invasion through precisely controlled chemical gradients and microenvironments, providing high-resolution real-time imaging data.
Learn More →How to Contact Us
Creative Biolabs provides a detailed suite of deliverables that bridge the gap between early-stage screening and advanced research. We address the translatability gap by providing data that quantifies a drug's impact on the entire metastatic journey.
We invite you to schedule a technical deep-dive to explore how our specialized metastasis models and longitudinal imaging datasets can be tailored to meet your specific research objectives and development goals - Get Started Today.
Reference
- Kusmartsev, Sergei et al. "Editorial: Cancer metastases: mechanisms of tumor dissemination, formation of metastatic niche and anti-metastatic therapy." Frontiers in immunology vol. 16 1746602. 25 Nov. 2025. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2025.1746602
Download our brochureLoading case studies...
Online Inquiry